PFE - FDA selects JN.1 variant for next COVID vaccine campaign
2024-06-07 12:11:30 ET
More on BioNTech, Moderna, etc.
- Pfizer: Surging Cancer Rates Will Boost Revenues
- Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript)
- Pfizer: Too Early For A Turnaround
- Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
- Novavax marketing application for COVID shot undergoes FDA review